Research Article

Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro

Table 3

Double combinations of the antibiotics against the clinical isolates.
(a)

Isolate numberAntibiotics (µg/mL)
CIP + AMKCIP + CAZCIP + PIP CIP + IMP IMP + PIP
MICMBCICITMICMBCICITMICMBCICITMICMBCICITMICMBCICIT

PA20.0620.1251I0.0620.1251I0.1250.1250I0.1250.1250I220I
PA30.0620.1251I0.0620.1251I0.0310.0312S0.1250.1250I16>1280I
PA90.2511I0.2511I0.1250.252S0.510I280I
PA114161I8>162S>16>160I>16>160I>32>320I
PA14181I181I280I280I2>320I
PA150.1250.1250I0.0620.1251I0.0620.1251I0.0620.1251I8>32−1I
PA180.0310.0620I0.0310.0620I0.0310.0620I0.0150.0621I32>32−2A
PA190.0310.1251I0.0620.1250I0.0620.1250I0.0310.1251I8>32−1I
PA202161I>16>160I>16>160I16>161I>32>320I
PA210.1250.250I0.1250.250I0.0620.251I0.0620.251I64>128−3A

(b)

Isolate numberAntibiotics (µg/mL)
AMK + CAZAMK + IMPAMK + PIP CAZ + IMP CAZ + PIP
MICMBCICITMICMBCICITMICMBCICITMICMBCICITMICMBCICIT

PA20.5041I181I281I28−1I0.2542S
PA3280I280I181I32>32−4A2162S
PA9142S181I2321I280I481I
PA114161I8160I4161I>32>320I32>321I
PA141161I2160I1161I2>320I0.543S
PA15142S4161I142S2321I4160I
PA180.5022S181I281I88−2A0.50.52S
PA19220I121I121I240I141I
PA20281I2161I2161I>32>320I>32>320I
PA210.2523S281I0.5022S1616−2A241I

(i) The IC (Interaction Code) is the change in the MIC of the most potent antibiotic in double or triple combination compared with the antibiotic alone.
(ii) The IC is assigned zero value if the MIC is not changed in combination, while a value of 1 or −1 is given if the MIC value decreases or increases by one dilution, respectively, in combination.
(iii) The IT (interaction type) is indifferent (I) when the IC value lies between −1 and <2, synergistic (S) if the IC value is ≥2, and antagonistic (A) if the IC value is ≤−2.